Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Emma Morris, Sattva S. Neelapu, Theodoros Giavridis, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 85-96
Open Access | Times Cited: 616

Showing 1-25 of 616 citing articles:

Harnessing cytokines and chemokines for cancer therapy
David Propper, Frances R. Balkwill
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 237-253
Closed Access | Times Cited: 603
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 338
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 209
Immunotherapy in breast cancer: an overview of current strategies and perspectives
Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 191
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa Hines, Tristan Knight, Kevin O. McNerney, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 438.e1-438.e16
Open Access | Times Cited: 141
Tumor‐Microenvironment‐Activatable Polymer Nano‐Immunomodulator for Precision Cancer Photoimmunotherapy
Jing Liu, Shasha He, Ying‐Li Luo, et al.
Advanced Materials (2021) Vol. 34, Iss. 8
Closed Access | Times Cited: 124
A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 118
The future of engineered immune cell therapies
Darrell J. Irvine, Marcela V. Maus, David Mooney, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 853-858
Open Access | Times Cited: 116
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Yun Chang, Xuechao Cai, Ramizah Syahirah, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 112
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004475-e004475
Open Access | Times Cited: 110
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Heinz Ludwig, Evangelos Terpos, Niels W.C.J. van de Donk, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 6, pp. e255-e269
Open Access | Times Cited: 87
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
Jae H. Park, Karthik Nath, Sean M. Devlin, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1710-1717
Closed Access | Times Cited: 81
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 81
Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
Yun Chang, Ramizah Syahirah, Xuepeng Wang, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111128-111128
Open Access | Times Cited: 75
Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
Sen Hee Tay, Michelle Min Xuan Toh, Yee Liang Thian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 73
Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 65
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice
Xiaomeng Hu, Karl Manner, Rowena DeJesus, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 48
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells
Michael Hiltensperger, Angela M. Krackhardt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Teng Liu, Pei Pei, Wenhao Shen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 46
Fungal infections: Immune defense, immunotherapies and vaccines
Jia Tong Loh, Kong‐Peng Lam
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114775-114775
Open Access | Times Cited: 46
Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
Sarah A. Holstein, Shakira J. Grant, Tanya M. Wildes
Journal of Clinical Oncology (2023) Vol. 41, Iss. 27, pp. 4416-4429
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top